Answers are grounded in this paper and cite their sources.
Introduction: Premature ovarian insufficiency (POI) is characterized by loss of ovarian function before age 40, resulting in elevated gonadotropins, reduced anti-Müllerian hormone (AMH), and limited fertility options. This systematic review evaluated the effects of platelet-rich plasma (PRP), secretome, and stem cell therapies on ovarian reserve restoration.Methods: Following PRISMA 2020 guidelines, PubMed, Cochrane, and MEDLINE were searched for human clinical studies published from 2020–2025. Prospective and retrospective studies involving women with POI receiving PRP, secretome, or stem cell interventions were included. Methodological quality was assessed using JBI Critical Appraisal Checklists.Results: Five studies involving 211 participants were analyzed. PRP showed a 100% reported success rate, with antral follicle count increases of 75 – 176%, AMH increases of 47 – 369%, and FSH reductions of 16 – 62%. Menstruation resumed in 60% of patients. Stem cell therapy showed a 50% overall success rate, while secretome therapy was associated with a 384% increase in euploid embryo production.Conclusion: PRP demonstrated promising improvements in ovarian reserve and menstrual function compared with stem cell and secretome therapies. However, limited studies and substantial heterogeneity warrant larger, long-term randomized controlled trials to establish efficacy, optimal protocols, and safety.Efek Terapi Platelet-Rich Plasma terhadap Cadangan Ovarium pada Wanita dengan Insufisiensi Ovarium PrematurAbstrakPendahuluan: Insufisiensi Ovarium Prematur (IOP) ditandai hilangnya fungsi ovarium sebelum usia 40 tahun, dengan peningkatan gonadotropin, penurunan AMH, dan keterbatasan pilihan terapi. Kehamilan spontan hanya terjadi pada 5 – 10% kasus. Tinjauan sistematis ini mengevaluasi pengaruh terapi platelet-rich plasma (PRP), sekretom, dan sel punca terhadap pemulihan cadangan ovarium.Metode: Mengikuti pedoman PRISMA 2020, pencarian dilakukan pada PubMed, Cochrane, dan MEDLINE untuk penelitian tahun 2020 – 2025. Studi klinis prospektif dan retrospektif pada manusia dengan IOP yang mendapat PRP, sekretom, atau sel punca disertakan. Kualitas metodologis dinilai menggunakan JBI Critical Appraisal Checklists.Hasil: Lima penelitian melibatkan 211 partisipan. PRP menunjukkan tingkat keberhasilan 100%, dengan peningkatan jumlah folikel antral 75 – 176%, AMH 47 – 369%, dan penurunan FSH 16–62%. Menstruasi kembali pada 60% pasien. Sel punca menunjukkan keberhasilan keseluruhan 50%, sedangkan sekretom meningkatkan produksi embrio euploid sebesar 384%.Kesimpulan: PRP menunjukkan hasil paling konsisten dan menjanjikan dalam pemulihan cadangan ovarium dan fungsi menstruasi dibandingkan sel punca dan sekretom. Namun, keterbatasan jumlah studi dan heterogenitas penelitian memerlukan uji klinis terkontrol acak yang lebih besar dan jangka panjang untuk memastikan efikasi, protokol optimal, dan keamanan.
No takes yet. Share an insight, caveat, or question.
Parhusip et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: